Risperidone
( DrugBank: Risperidone / KEGG DRUG: Risperidone )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 8 | Huntington disease | 2 |
| 156 | Rett syndrome | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 187 | Kabuki syndrome | 1 |
8. Huntington disease
Clinical trials : 276 / Drugs : 185 - (DrugBank : 58) / Drug target genes : 86 - Drug target pathways : 160
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
156. Rett syndrome
Clinical trials : 55 / Drugs : 51 - (DrugBank : 22) / Drug target genes : 77 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
187. Kabuki syndrome
Clinical trials : 4 / Drugs : 6 - (DrugBank : 2) / Drug target genes : 3 - Drug target pathways : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|